MarketPeel
Insider Trading Intelligence
FF

Faye Feller

GERN
EVP, CHIEF MEDICAL OFFICER · GERON CORP · CIK 0001937361
FILING MIX · LIFETIME71%/29%
BUYS
10
SELLS
4
TOTAL VALUE
$1.68M
COMPANIES
1
ACTIVE SINCE
Jul 2022
HOLDINGS NOW
0
AVG SELL PX
$4.63
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Faye Feller, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-7.34%+2.14%-9.48%-9.48%
14d1+100.00%-8.93%+1.65%-10.58%-10.58%
30d1+100.00%-8.73%+5.13%-13.86%-13.86%
60d1+100.00%-6.75%-0.18%-6.57%-6.57%
90d1+100.00%-12.50%+2.34%-14.84%-14.84%
180d1+100.00%-22.02%+14.19%-36.21%-36.21%
1y1+100.00%-68.25%+14.02%-82.27%-82.27%
2y1+100.00%-77.58%+37.60%-115.18%-115.18%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GERN · 0 shares · as of Jun 10, 2024
0187,500375,000562,500750,00020232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
FLOW · 10 buys / 4 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GERN
GERON CORP
PURCHASE
EVP, Chief Medical Officer
20,000$1.06$21.2K20,000Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
PURCHASE
EVP, Chief Medical Officer
155,400$1.30$201.2K155,400Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
SALE
EVP, Chief Medical Officer
20,0000Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
SALE
EVP, Chief Medical Officer
155,4000Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
PURCHASE
EVP, Chief Medical Officer
112,500$1.06$119.3K112,500Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
SALE
EVP, Chief Medical Officer
112,50087,500Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
SALE
EVP, Chief Medical Officer
287,900$4.63$1.33M0Jun 10, 2024Jun 12, 2024View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
50,00050,000Jun 6, 2024Jun 7, 2024View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
200,000200,000Jun 6, 2024Jun 7, 2024View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
750,000750,000Feb 14, 2024Feb 16, 2024View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
20,00020,000Aug 15, 2023Sep 21, 2023View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
180,000180,000Aug 15, 2023Sep 21, 2023View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
540,000540,000Feb 22, 2023Feb 24, 2023View →
GERN
GERON CORP
PURCHASEGRANT
Stock grant
120,000120,000Jul 8, 2022Jul 12, 2022View →
Other insiders · GERN
Loading peer insiders…
About this filer
CIK 0001937361
ROLE
EVP, Chief Medical Officer
PRIMARY
GERN
COMPANIES
1
ACTIVE SINCE
Jul 2022
MARKETPEEL · /INSIDER/0001937361DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback